Clinical Trial Update: Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating multi-instillations of apaziquone for non-muscle invasive bladder cancer was terminated, and results on efficacy and safety have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Apaziquone (apaziquone)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Bladder Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-12-13